Stockreport

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics, Inc.  (SYRE) 
PDF WALTHAM, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE) (the “Company” or “Spyre”), a clinical-stage biotechnology company pioneering [Read more]